Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $8.35 Million - $10.9 Million
-950,511 Reduced 38.6%
1,511,789 $17.3 Million
Q3 2023

Nov 14, 2023

BUY
$8.25 - $11.35 $12.5 Million - $17.2 Million
1,518,500 Added 160.89%
2,462,300 $23.7 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $9.53 Million - $10.9 Million
943,800 New
943,800 $10 Million
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $12.6 Million - $16.5 Million
-1,375,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$8.22 - $14.0 $5.75 Million - $9.8 Million
700,000 Added 103.7%
1,375,000 $18.3 Million
Q2 2019

Aug 14, 2019

SELL
$9.8 - $12.89 $11.8 Million - $15.5 Million
-1,200,000 Reduced 64.0%
675,000 $7.39 Million
Q4 2018

Feb 14, 2019

SELL
$7.8 - $16.13 $3.9 Million - $8.06 Million
-500,000 Reduced 21.05%
1,875,000 $19.4 Million
Q3 2018

Nov 14, 2018

BUY
$14.31 - $17.65 $7.16 Million - $8.83 Million
500,000 Added 26.67%
2,375,000 $43.8 Million
Q1 2018

May 15, 2018

SELL
$11.13 - $13.63 $97,866 - $119,848
-8,793 Reduced 0.47%
1,875,000 $28.9 Million
Q4 2017

Feb 14, 2018

SELL
$12.16 - $14.58 $12.4 Million - $14.8 Million
-1,016,207 Reduced 35.04%
1,883,793 $28.2 Million
Q3 2017

Nov 14, 2017

BUY
$12.07 - $14.87 $35 Million - $43.1 Million
2,900,000
2,900,000 $45.7 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.